Patent ‘March-In’ Policy Shift Will Likely Drive Uncertainty More Than Price Drops

 
• By Brenda Sandburg
  
Marching in
New policy on march-in rights to license patents directs government agencies to consider product pricing • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Pink Sheet